Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1,605,991
-
Shares change
-
+1,605,991
-
Total reported value, excl. options
-
$6,624,465
-
Value change
-
+$6,624,465
-
Number of buys
-
19
-
Price
-
$4.13
Significant Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q3 2021
19 filings reported holding CRDL - Cardiol Therapeutics Inc. - Class A Common Shares as of Q3 2021.
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,605,991 shares
of 98,656,192 outstanding shares and own 1.63% of the company stock.
Largest 10 shareholders include Mirae Asset Global Investments Co., Ltd. (1,043,704 shares), RENAISSANCE TECHNOLOGIES LLC (144,900 shares), JANE STREET GROUP, LLC (79,431 shares), Virtu Financial LLC (75,819 shares), GEODE CAPITAL MANAGEMENT, LLC (52,435 shares), Vident Investment Advisory, LLC (50,566 shares), TWO SIGMA ADVISERS, LP (31,100 shares), MORGAN STANLEY (27,090 shares), Marble Harbor Investment Counsel, LLC (22,000 shares), and GOLDMAN SACHS GROUP INC (19,100 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.